Position in ESPR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
New position
Shares Held
171,250
first reported quarter
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in ESPR
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$0
PutShares
20,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CSS LLC/IL holds $5,738,432 across 10 Drug Manufacturers - Specialty & Generic names. ESPR ranks #10 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
31,338 | $1,086,488 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
6,350 | $1,070,229 | |
| 3 | ZTS |
Zoetis Inc.
|
14,510 | $1,042,688 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
1,892 | $1,025,142 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
27,070 | $917,131 | |
| 6 | TRLV |
Trulieve Cannabis Corp.
|
29,875 | $293,671 | |
| 7 | VTRS |
Viatris Inc
|
11,120 | $176,585 | |
| 8 | YCBD |
cbdMD, Inc.
|
137,621 | $92,618 |
All Filings in ESPR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 171,250 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | — | 20,000 | Put | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||